ENANTA PHARMACEUTICALS

enanta-pharmaceuticals-logo

Enanta Pharmaceuticals, Inc., a research and development company, engages in the discovery, development, and promotion of small molecule drugs in the areas of anti-infective. It develops protease, NS5A, polymerase, and cyclophilin-based inhibitors for the treatment of hepatitis C virus (HCV). The company also develops ABT-450/r, an oral protease inhibitor for the treatment of hepatitis C (HCV) infection. In addition, it develops Bicyclolides, a macrolide antibiotic, which overcomes bacteri... al resistance; and EDP-420, a bicyclolide antibiotic for the treatment of community-acquired pneumonia. The company's antibacterial focus areas include superbugs, respiratory tract infections, and intravenous and oral treatments for hospital and community MRSA. The company has strategic alliances with Abbott Laboratories; and Shionogi & Co., LTD. Enanta Pharmaceuticals, Inc. was formerly known as NovirX, Inc. and changed its name to Enanta Pharmaceuticals, Inc. in May 1999. The company was founded in 1998 and is based in Watertown, Massachusetts.

#SimilarOrganizations #People #Financial #Event #Website #More

ENANTA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1998-01-01

Address:
Watertown, Massachusetts, United States

Country:
United States

Website Url:
http://www.enanta.com

Total Employee:
51+

Status:
Active

Contact:
6176070530

Email Addresses:
[email protected]

Total Funding:
84.6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Domain Not Resolving


Similar Organizations

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.


Current Advisors List

marc-goldberg_image

Marc Goldberg Board of Directors @ Enanta Pharmaceuticals
Board_member
2002-01-01

terry-vance_image

Terry Vance Board of Directors @ Enanta Pharmaceuticals
Board_member
2011-06-01

helmut-m-schühsler_image

Helmut M. Schühsler Chairman of the Supervisory Board @ Enanta Pharmaceuticals
Board_member

david-poorvin_image

David Poorvin Board of Directors @ Enanta Pharmaceuticals
Board_member
2004-01-01

not_available_image

Ernst-Günter Afting Board of Directors @ Enanta Pharmaceuticals
Board_member
1995-01-01

not_available_image

Bruce L.A. Carter Board of Directors @ Enanta Pharmaceuticals
Board_member
2013-11-01

stephen-buckley-jr_image

Stephen Buckley, Jr Board of Directors @ Enanta Pharmaceuticals
Board_member
2012-01-01

Current Employees Featured

jay-r-luly_image

Jay R. Luly
Jay R. Luly President, Chief Executive Officer and Director @ Enanta Pharmaceuticals
President, Chief Executive Officer and Director
2003-07-01

yat-sun-or_image

Yat Sun Or
Yat Sun Or Senior Vice President, Research & Development and Chief Scientific Officer @ Enanta Pharmaceuticals
Senior Vice President, Research & Development and Chief Scientific Officer
1999-11-01

paul-j-mellett_image

Paul J. Mellett
Paul J. Mellett Senior Vice President, Finance & Administration and Chief Financial Officer @ Enanta Pharmaceuticals
Senior Vice President, Finance & Administration and Chief Financial Officer
2003-09-01

scott-rottinghaus_image

Scott Rottinghaus
Scott Rottinghaus Chief Medical Officer @ Enanta Pharmaceuticals
Chief Medical Officer
2022-08-01

Stock Details


Company's stock symbol is NASDAQ:ENTA

Investors List

thuja-capital_image

Thuja Capital

Thuja Capital investment in Venture Round - Enanta Pharmaceuticals

bioventures-investors_image

Bioventures Investors

Bioventures Investors investment in Venture Round - Enanta Pharmaceuticals

tvm-techno-venture-management_image

Techno Venture Management

Techno Venture Management investment in Venture Round - Enanta Pharmaceuticals

oxford-bioscience-partners_image

Oxford Bioscience Partners

Oxford Bioscience Partners investment in Venture Round - Enanta Pharmaceuticals

advent-international_image

Advent International

Advent International investment in Venture Round - Enanta Pharmaceuticals

oxford-bioscience-partners_image

Oxford Bioscience Partners

Oxford Bioscience Partners investment in Venture Round - Enanta Pharmaceuticals

bioventures-investors_image

Bioventures Investors

Bioventures Investors investment in Venture Round - Enanta Pharmaceuticals

swiss-life-private-equity-partners_image

Swiss Life Private Equity Partners

Swiss Life Private Equity Partners investment in Venture Round - Enanta Pharmaceuticals

wheatley-medtech-partners_image

Wheatley MedTech Partners

Wheatley MedTech Partners investment in Venture Round - Enanta Pharmaceuticals

yasuda-enterprise-development_image

Yasuda Enterprise Development

Yasuda Enterprise Development investment in Venture Round - Enanta Pharmaceuticals

Official Site Inspections

http://www.enanta.com Semrush global rank: 226.61 K Semrush visits lastest month: 320.13 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Enanta Pharmaceuticals"

Governance - Enanta Pharmaceuticals

For an organization of our size, Enanta has a robust risk management program. This includes a security program, business continuity plan and a comprehensive set of other IT policies. The CFO has primary responsibility for risk …See details»

Corporate Responsibility Overview - Enanta …

Our disclosures reflect what is important within the context of Enanta: a small U.S. organization with less than 200 employees, two leased buildings, outsourced manufacturing and out-licensed commercialization of our first two product …See details»

Enanta Pharmaceuticals - Crunchbase Company Profile …

The company has strategic alliances with Abbott Laboratories; and Shionogi & Co., LTD. Enanta Pharmaceuticals, Inc. was formerly known as NovirX, Inc. and changed its name to Enanta Pharmaceuticals, Inc. in May 1999. The company …See details»

Enanta Pharmaceuticals - Company Profile & Staff Directory

Enanta Pharmaceuticals is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for …See details»

ENANTA PHARMACEUTICALS, INC. CORPORATE GOVERNANCE …

ENANTA PHARMACEUTICALS, INC. CORPORATE GOVERNANCE GUIDELINES A. Purpose The Board of Directors (the “Board”) of Enanta Pharmaceuticals, Inc. (the “Company”) has ...See details»

Enanta Pharmaceuticals, Inc. - Scientist.com

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small …See details»

Enanta Pharmaceuticals - Overview, News & Similar companies

May 6, 2024 Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. …See details»

Enanta Pharmaceuticals - Funding, Financials, Valuation & Investors

Enanta Pharmaceuticals is registered under the ticker NASDAQ:ENTA . Their stock opened with $14.00 in its Mar 21, 2013 IPO. Stock Symbol NASDAQ:ENTA ; Money Raised at IPO $56M; …See details»

Social - Enanta Pharmaceuticals

Enanta participates in other activities including assembling birthday party kits for FamilyAid, a Greater Boston company that aids children and parents facing homelessness and donating …See details»

Enanta Pharmaceuticals - Craft

Oct 29, 2024 Enanta Pharmaceuticals has 5 employees at their 1 location and $67.64 m in annual revenue in FY 2024. See insights on Enanta Pharmaceuticals including office …See details»

Enanta Pharmaceuticals Reports Financial Results for its Fiscal …

Nov 25, 2024 Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024 Business Wire Mon, Nov 25, 2024, 4:01 PM 13 min readSee details»

Enanta Pharmaceuticals Reports Financial Results for its Fiscal …

Each quarter, Enanta records 100% of the royalty earned as revenue and then amortizes the debt liability proportionally as 54.5% of the cash royalty payments are paid to OMERS through June …See details»

Enanta Pharmaceuticals, Inc. (ENTA) - Yahoo Finance Canada

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises …See details»

About Us - Enanta Pharmaceuticals

Enanta is a clinical stage biotechnology company dedicated to creating oral drugs with an emphasis on indications in virology and immunology. Our story began in 1995 when we grew …See details»

Working at Enanta Pharmaceuticals - Zippia

Mar 14, 2024 Enanta Pharmaceuticals, Inc. was formerly known as NovirX, Inc. and changed its name to Enanta Pharmaceuticals, Inc. in May 1999. The company was founded in 1998 and is …See details»

4 Analysts Assess Enanta Pharma: What You Need To Know

Nov 26, 2024 Net Margin: Enanta Pharma's net margin is impressive, surpassing industry averages. With a net margin of -126.08%, the company demonstrates strong profitability and …See details»

About - Enanta Pharmaceuticals

Contact. Enanta Pharmaceuticals, Inc. Headquarters 4 Kingsbury Avenue Watertown, MA 02472 (617) 607-0800 [email protected]See details»

Enanta Pharmaceuticals | ENTA Stock Price, Company Overview

Enanta Pharmaceuticals (ENTA) Stock Price Performance. Enanta Pharmaceuticals (ENTA) Stock Key Data. Summary Additional Data Analysts Historical Quotes. Key Data. Previous …See details»

Careers - Enanta Pharmaceuticals

We are also involved in activities such as partnering with Victory Programs, a Boston-based nonprofit organization, to assemble students’ backpacks for back to school season. Core …See details»

linkstock.net © 2022. All rights reserved